108 related articles for article (PubMed ID: 8012933)
1. Investigation of c-myc oncogene amplification in colorectal cancer.
Kozma L; Kiss I; Szakáll S; Ember I
Cancer Lett; 1994 Jun; 81(2):165-9. PubMed ID: 8012933
[TBL] [Abstract][Full Text] [Related]
2. C-myc amplification and cluster analysis in human gastric carcinoma.
Kozma L; Kiss I; Hajdú J; Szentkereszty Z; Szakáll S; Ember I
Anticancer Res; 2001; 21(1B):707-10. PubMed ID: 11299830
[TBL] [Abstract][Full Text] [Related]
3. Is the presence of distant metastasis associated with c-myc amplification in gastric cancer?
Hajdú J; Kozma L; Kiss I; Szentkereszty Z; Szakáll S; Ember I
Acta Chir Hung; 1997; 36(1-4):119-21. PubMed ID: 9408311
[TBL] [Abstract][Full Text] [Related]
4. Moderate amplifications of the c-myc gene correlate with molecular and clinicopathological parameters in colorectal cancer.
Masramon L; Arribas R; Tórtola S; Perucho M; Peinado MA
Br J Cancer; 1998 Jun; 77(12):2349-56. PubMed ID: 9649157
[TBL] [Abstract][Full Text] [Related]
5. Fish detected p53 deletion and N-MYC amplification in colorectal cancer.
Ozakyol A; Ozdemir M; Artan S
Hepatogastroenterology; 2006; 53(68):192-5. PubMed ID: 16608022
[TBL] [Abstract][Full Text] [Related]
6. The prognostic role of c-MYC amplification in schistosomiasis-associated colorectal cancer.
Pan W; Wang W; Huang J; Lu K; Huang S; Jiang D; Bu D; Liu J; Jing H; Yao J; Hou Y
Jpn J Clin Oncol; 2020 Apr; 50(4):446-455. PubMed ID: 32297641
[TBL] [Abstract][Full Text] [Related]
7. Investigation of c-myc and K-ras amplification in renal clear cell adenocarcinoma.
Kozma L; Kiss I; Nagy A; Szakáll S; Ember I
Cancer Lett; 1997 Jan; 111(1-2):127-31. PubMed ID: 9022137
[TBL] [Abstract][Full Text] [Related]
8. Overexpression and amplification of c-myc during progression of human colorectal cancer.
Rochlitz CF; Herrmann R; de Kant E
Oncology; 1996; 53(6):448-54. PubMed ID: 8960139
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous expression and association of beta-catenin, p16 and c-myc in multistage colorectal tumorigenesis and progression detected by tissue microarray.
Xie D; Sham JS; Zeng WF; Lin HL; Che LH; Wu HX; Wen JM; Fang Y; Hu L; Guan XY
Int J Cancer; 2003 Dec; 107(6):896-902. PubMed ID: 14601048
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancer.
Kwak Y; Yun S; Nam SK; Seo AN; Lee KS; Shin E; Oh HK; Kim DW; Kang SB; Kim WH; Lee HS
J Transl Med; 2017 Aug; 15(1):167. PubMed ID: 28764718
[TBL] [Abstract][Full Text] [Related]
11. Aggressive subtypes of human colorectal tumors frequently exhibit amplification of the c-myc gene.
Heerdt BG; Molinas S; Deitch D; Augenlicht LH
Oncogene; 1991 Jan; 6(1):125-9. PubMed ID: 1992440
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of the c-myc proto-oncogene in colorectal carcinoma.
Smith DR; Myint T; Goh HS
Br J Cancer; 1993 Aug; 68(2):407-13. PubMed ID: 8347498
[TBL] [Abstract][Full Text] [Related]
13. Two distinct amplification events of the c-myc locus in a colorectal tumour.
La Farina M; Bellavia M; Tagliavia M; Eterno V; Colomba P; Scibetta A; Albanese I
J Cell Physiol; 2008 Oct; 217(1):34-9. PubMed ID: 18446811
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of myc and chromosome 8 copy number in colorectal cancer using interphase cytogenetics.
Obara K; Yokoyama M; Asano G; Tanaka S
Int J Oncol; 2001 Feb; 18(2):233-9. PubMed ID: 11172587
[TBL] [Abstract][Full Text] [Related]
15. [Amplification of C-myc oncogene in squamous cell carcinoma of the larynx].
Liu S; Lin D; Hong B; Huang G
Hua Xi Yi Ke Da Xue Xue Bao; 1994 Mar; 25(1):41-4. PubMed ID: 8070770
[TBL] [Abstract][Full Text] [Related]
16. A study of c-myc oncogene expression and amplification in colorectal cancer.
Wang J; Li L; Li S; Cui H; Shen G
Chin Med Sci J; 1994 Mar; 9(1):24-8. PubMed ID: 8086630
[TBL] [Abstract][Full Text] [Related]
17. HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer.
Al-Kuraya K; Novotny H; Bavi P; Siraj AK; Uddin S; Ezzat A; Sanea NA; Al-Dayel F; Al-Mana H; Sheikh SS; Mirlacher M; Tapia C; Simon R; Sauter G; Terracciano L; Tornillo L
J Clin Pathol; 2007 Jul; 60(7):768-72. PubMed ID: 16882699
[TBL] [Abstract][Full Text] [Related]
18. MDM2 gene amplification in colorectal cancer is associated with disease progression at the primary site, but inversely correlated with distant metastasis.
Sugano N; Suda T; Godai TI; Tsuchida K; Shiozawa M; Sekiguchi H; Yoshihara M; Matsukuma S; Sakuma Y; Tsuchiya E; Kameda Y; Akaike M; Miyagi Y
Genes Chromosomes Cancer; 2010 Jul; 49(7):620-9. PubMed ID: 20461754
[TBL] [Abstract][Full Text] [Related]
19. c-myc oncogene amplification and cytometric DNA ploidy pattern as prognostic factors in musculoskeletal neoplasms.
Barrios C; Castresana JS; Falkmer UG; Rosendahl I; Kreicbergs A
Int J Cancer; 1994 Sep; 58(6):781-6. PubMed ID: 7927868
[TBL] [Abstract][Full Text] [Related]
20. c-myc mRNA overexpression is associated with lymph node metastasis in colorectal cancer.
Sato K; Miyahara M; Saito T; Kobayashi M
Eur J Cancer; 1994; 30A(8):1113-7. PubMed ID: 7654441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
